Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Verrica Pharmaceuticals (VRCA) Operating Margin (2021 - 2025)

Verrica Pharmaceuticals has reported Operating Margin over the past 5 years, most recently at 141.24% for Q4 2025.

  • Quarterly results put Operating Margin at 141.24% for Q4 2025, up 317562.0% from a year ago — trailing twelve months through Dec 2025 was 34.25% (up 55812.0% YoY), and the annual figure for FY2025 was 34.25%, up 83700.0%.
  • Operating Margin for Q4 2025 was 141.24% at Verrica Pharmaceuticals, down from 11.34% in the prior quarter.
  • Over the last five years, Operating Margin for VRCA hit a ceiling of 17.41% in Q3 2022 and a floor of 19159.46% in Q1 2023.
  • Median Operating Margin over the past 5 years was 819.92% (2023), compared with a mean of 2837.44%.
  • Biggest five-year swings in Operating Margin: plummeted -1744020bps in 2023 and later soared 1867334bps in 2024.
  • Verrica Pharmaceuticals' Operating Margin stood at 0.5% in 2021, then tumbled by -1826865bps to 9133.82% in 2022, then skyrocketed by 87bps to 1163.78% in 2023, then tumbled by -185bps to 3316.86% in 2024, then skyrocketed by 96bps to 141.24% in 2025.
  • The last three reported values for Operating Margin were 141.24% (Q4 2025), 11.34% (Q3 2025), and 11.89% (Q2 2025) per Business Quant data.